NCT01738841View on ClinicalTrials.gov

Safety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the Philippines

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

August 31, 2013

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
MumpsRubellaMeaslesVaricella
Interventions
BIOLOGICAL

Priorix-Tetra™

Single dose, subcutaneous injection

OTHER

Safety data collection

Recording of adverse events, using diary cards

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY